1. Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection
- Author
-
Feld, Jordan J, King, Wendy C, Ghany, Marc G, Chang, Kyong-Mi, Terrault, Norah, Perrillo, Robert P, Khalili, Mandana, Hinerman, Amanda S, LA. Janssen, Harry, Lok, Anna S, and Network, Hepatitis B Research
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Digestive Diseases ,Hepatitis - B ,Prevention ,Hepatitis ,Chronic Liver Disease and Cirrhosis ,Infectious Diseases ,Clinical Trials and Supportive Activities ,Clinical Research ,Liver Disease ,Good Health and Well Being ,Adult ,Male ,Humans ,Aged ,Female ,Hepatitis B ,Chronic ,Hepatitis B virus ,Hepatitis B e Antigens ,Cohort Studies ,Cross-Sectional Studies ,Hepatitis B Surface Antigens ,Alanine Transaminase ,DNA ,Viral ,Immune Tolerance ,Chronic HBV Infection ,Immune Active ,Immunotolerant ,Phase Transition ,Hepatitis B Research Network ,Gastroenterology & Hepatology ,Clinical sciences - Abstract
Background & aimsMost patients in the immunotolerant (IT) phase of chronic hepatitis B (CHB) transition to the immune active (IA-hepatitis B surface antigen [HBeAg]+) phase by early adulthood. We examined characteristics of adults in the IT vs IA-HBeAg+ phase and rate of transition from IT to other phases of CHB, with a focus on those ≥40 years.MethodsDemographic, clinical, and virologic characteristics of participants in the Hepatitis B Research Network adult cohort study with IT CHB (alanine aminotransferase ≤1.5 × upper limit of normal, hepatitis B virus DNA >107 IU/mL) were compared by age category, and to those with IA-HBeAg+ CHB in cross-sectional analysis. This study received institutional review board approval at all participating centers.ResultsOf 107 adult IT participants, 52 (48%) were
- Published
- 2023